about
HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptorSolution structure of Der f 2, the major mite allergen for atopic diseasesTranscriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injuryThe RING finger protein, RNF8, interacts with retinoid X receptor alpha and enhances its transcription-stimulating activityInhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosisAlpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.Fungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase.TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interactionTranscriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma.High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.The effect of acyclic retinoid on the metabolomic profiles of hepatocytes and hepatocellular carcinoma cells.Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expressionEicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient miceRetinoids in cancer chemoprevention.Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer managementCAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors.Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cellsLipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration.Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid.A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1Azaspirene, a fungal product, inhibits angiogenesis by blocking Raf-1 activation.Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic developmentRecent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways.New insights into the functions and localization of nuclear transglutaminase 2.FANTOM5 CAGE profiles of human and mouse samplesIn situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules.Brain infarction correlates more closely with acrolein than with reactive oxygen species.Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.Phosphorylated retinoid X receptor alpha loses its heterodimeric activity with retinoic acid receptor beta.Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma.9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90.Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells.
P50
Q24308693-8C1E43DF-7F7F-4D23-BAF4-33C36A82E095Q27748760-BEED8E22-B284-4BA0-A629-961117974319Q28215010-9DC9EE5A-0606-4205-830B-2F65E9141DACQ28246541-3EE3650E-2932-4059-BD5C-5EF1EEB37E51Q33303650-8BE4F4D3-8437-401B-9357-E6DE78909EE3Q33662935-93D958E3-0DC9-4406-AB9D-A40D4CA6E102Q33673746-733C0631-89D3-4E5C-A6DB-378EAD4C9360Q33881464-9F05B4BF-EE8D-4BF7-A53B-C2C4EB25793AQ33899390-EE700B31-6505-4558-A3D0-41FD24299B9EQ33911192-8E154170-9D1F-44D4-93DA-9BCEA212741BQ34381391-52834536-3105-4E99-91A7-D3B1DACAB58FQ34506882-489F3E84-3F1D-43CB-BB5C-9D50392D0732Q34536138-026CD5BA-44D7-47DA-9813-61CCA0504BE7Q35077773-83A243F8-56DE-4F32-B7D2-4569D9AC4191Q35126674-10109E81-65D6-41FF-9642-9B92397B4A11Q35588868-FB95C7C1-5717-41F0-93B4-8728F870CA39Q35768495-E06CA5B7-32DE-418A-9BC5-FC4CB0D8202DQ36172739-B4EEE5DB-815F-4210-92C4-452A3D9C713FQ36333693-0A68FCD7-84D5-4922-B83C-3CA410A91127Q36383154-D22017A7-A1CF-44A2-BF86-E2B6CCB9B9F6Q36529887-55BE85CB-B66C-44AE-9ED0-67E731ABF0DFQ36770932-A631E2CF-8D80-4945-91B4-294F76FD84F9Q36777944-5E8D7173-6470-4C91-BE68-B183816A0BBCQ37124999-A04B2D81-84A1-4632-AAE2-816715976C1BQ37203920-CE478504-6C8F-474B-883F-A66A3628538EQ37255857-848B74B7-BCBA-48DD-AC3E-98E3A98488F1Q37700761-D0527A29-09F3-4E6A-BA06-49C1966B07ABQ37869760-FA2085A5-5AB3-46D0-B447-AED7AAB26AD4Q37952438-12E06048-888E-41AC-8529-57B5EF98DC99Q38604042-90E4436E-F787-4D4A-A09A-0802D89680FCQ38819973-9F67322E-660F-4E0A-910A-9AA2B016BC04Q39094479-94C02DA0-6E5B-4011-9CA7-6C1B00CFDEFAQ39582221-2441D1B4-462C-497F-9A47-2A60C8695872Q39615407-162E5BE8-7AA0-4C88-83D7-A577D8BB9279Q40004554-12AE5F7F-85DB-4C89-B7CB-ADDE12360DB4Q40075358-E7FA54D9-709D-4D61-A791-38451517053EQ40176027-FCA40C18-2FAC-46DA-835B-BA739058FD52Q40752916-D77C5CAD-0AA5-475A-9247-914D1F279925Q41099992-40E439D2-979A-421F-8FF2-B6BBE743E093Q41440879-2A6C374E-CD5B-41FC-B334-5B89F49083D7
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-5252-1612
@en
name
Soichi Kojima
@ast
Soichi Kojima
@en
Soichi Kojima
@es
Soichi Kojima
@nl
Soichi Kojima
@sl
type
label
Soichi Kojima
@ast
Soichi Kojima
@en
Soichi Kojima
@es
Soichi Kojima
@nl
Soichi Kojima
@sl
prefLabel
Soichi Kojima
@ast
Soichi Kojima
@en
Soichi Kojima
@es
Soichi Kojima
@nl
Soichi Kojima
@sl
P108
P1053
N-7104-2015
P106
P21
P31
P3829
P496
0000-0002-5252-1612